FDA-cleared profile

LUMINOS Q.namix T; LUMINOS Q.namix R

Siemens Medical Solutions · Fluoroscopy/Angiography · FDA-cleared (510(k))

Authorized purpose: LUMINOS Q.namix T and LUMINOS Q.namix R are multifunctional radiography and fluoroscopy systems for routine radiography and fluoroscopic examinations including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric workflows; they are not mammography systems.

Clinical role
Fluoroscopic or radiographic acquisition, visualization, guidance, and release-specific image processing.
Images and patients
Fluoroscopy/Angiography · Multi-region
Key limitation
Keep in mind: LUMINOS Q.namix T and LUMINOS Q.namix R are not intended to be used for mammography examinations. Furthermore, the operators are healthcare professionals familiar with and responsible for the X-ray examinations to be performed.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: LUMINOS Q.namix T and LUMINOS Q.namix R are multifunctional radiography and fluoroscopy systems for routine radiography and fluoroscopic examinations including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric workflows; they are not mammography systems.
  • Which images or clinical context are in scope?Modality: Fluoroscopy/Angiography Anatomy or clinical context: Multi-region Input: An X-ray pattern.
  • Who uses it?Intended users: The operators are healthcare professionals familiar with and responsible for the X-ray examinations to be performed.
  • What does the software produce?Output: LUMINOS Q.namix T and LUMINOS Q.namix R are devices intended to visualize anatomical structures by converting an X-ray pattern into a visible image.
  • What is its most important limitation?Key limitation: LUMINOS Q.namix T and LUMINOS Q.namix R are not intended to be used for mammography examinations. Furthermore, the operators are healthcare professionals familiar with and responsible for the X-ray examinations to be performed.

Clinical takeaway. Clinical role: LUMINOS Q.namix T and LUMINOS Q.namix R are multifunctional radiography and fluoroscopy systems for routine radiography and fluoroscopic examinations including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric workflows; they are not mammography systems.

Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports non-clinical testing showing the systems comply with the voluntary standards it lists. Expert evaluations of the new detectors (X.fluoro and X.wi-D24) at hospitals in Germany and Belgium found the images acceptable for diagnostic in radiography & fluoroscopy, and a US board-certified radiologist's clinical image quality evaluation of X.fluoro images and fluorography studies from different body regions found them qualified for proper diagnosis. Results are as reported in the FDA submission, not independent validation.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
LUMINOS Q.namix T and LUMINOS Q.namix R are multifunctional radiography and fluoroscopy systems for routine radiography and fluoroscopic examinations including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric workflows; they are not mammography systems.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Workflow role
Fluoroscopic or radiographic acquisition, visualization, guidance, and release-specific image processing.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
An X-ray pattern.
  • Exact FDA submission
  • Checked 2026-09-19

The packet directly states that the devices convert an X-ray pattern into a visible image; patient-positioning and procedure-specific input additions are not retained.

Output and clinician action
LUMINOS Q.namix T and LUMINOS Q.namix R are devices intended to visualize anatomical structures by converting an X-ray pattern into a visible image.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet supports a visible image of anatomical structures and diagnostic radiography/fluoroscopy images, not the current reformats, overlays, measurements, or guidance-view list.

Care setting
Hospital radiography, fluoroscopy, interventional, vascular, cardiac, or procedural departments.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
The operators are healthcare professionals familiar with and responsible for the X-ray examinations to be performed.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet names healthcare professionals responsible for the X-ray examinations; it does not name the dossier's specific physician and technologist roles.

Limitations
LUMINOS Q.namix T and LUMINOS Q.namix R are not intended to be used for mammography examinations. Furthermore, the operators are healthcare professionals familiar with and responsible for the X-ray examinations to be performed.
  • Exact FDA submission
  • Checked 2026-09-19

These are the direct mammography exclusion and operator-responsibility statements in the packet.

Evidence summary
The exact FDA document reports non-clinical testing showing the systems comply with the voluntary standards it lists. Expert evaluations of the new detectors (X.fluoro and X.wi-D24) at hospitals in Germany and Belgium found the images acceptable for diagnostic in radiography & fluoroscopy, and a US board-certified radiologist's clinical image quality evaluation of X.fluoro images and fluorography studies from different body regions found them qualified for proper diagnosis. Results are as reported in the FDA submission, not independent validation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The LUMINOS Q.namix T/LUMINOS Q.namix R systems were tested and comply with the voluntary standards listed in the table below:" … "For the new detectors, X.fluoro and X.wi-D24, expert evaluations according to". Read from the exact FDA decision document on 2026-11-14.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA document reports non-clinical testing showing the systems comply with the voluntary standards it lists. Expert evaluations of the new detectors (X.fluoro and X.wi-D24) at hospitals in Germany and Belgium found the images acceptable for diagnostic in radiography & fluoroscopy, and a US board-certified radiologist's clinical image quality evaluation of X.fluoro images and fluorography studies from different body regions found them qualified for proper diagnosis. Results are as reported in the FDA submission, not independent validation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The LUMINOS Q.namix T/LUMINOS Q.namix R systems were tested and comply with the voluntary standards listed in the table below:" … "For the new detectors, X.fluoro and X.wi-D24, expert evaluations according to". Read from the exact FDA decision document on 2026-11-14.

Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K250660 FDA performance package for LUMINOS Q.namix T; LUMINOS Q.namix R

  • DesignManufacturer detector, system, software, image-quality, and multi-hospital clinical-expert evaluation
  • PopulationRoutine radiography and fluoroscopy including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric examinations at 4 hospitals
  • Scopeexact submission
  • Tested versionLUMINOS Q.namix T/R
  • Sites4
  • IndependenceSponsor or vendor study

K250660

Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
2 exact-submission FDA recall records in the 2026-09-02 openFDA snapshot identify K250660. Affected model, version, unit, correction, and current manufacturer instructions still require local confirmation. FDA recall Z-1174-2026 is Open, Classified for Interventional Fluoroscopic X-Ray System: LUMINOS Q.namix R; Siemens Material Number (SMN): 11574002; With Software Version VB10D-SP02. FDA reason: Ortho images acquired with preset automatic horizontal flip are not flipped and when acquiring single images, there is the possibility that an image of a previous patient may be processed. FDA action: On December 29, 2025 URGENT: MEDICAL DEVICE CORRECTION letters were sent to customers. Actions to be taken: Issue 1: Ortho images acquired with preset automatic horizontal flip are not flipped: For ortho examinations, no clinical protocols should be used where the automatic horizontal flip function is active. Issue 2: When acquiring single images, there is the possibility that an image of a previous patient may be processed: a. When acquiring single images with the Dynamic X.fluoro detector, the above-mentioned error message should be observed, and the system should be restarted when it appears. b. Images planned at the Bucky Wall Stand should be acquired on the basic unit or with a mobile detector. Should a single image on the Bucky Wall Stand in horizontal orientation be inevitable, the system must be restarted beforehand. How will the problem be resolved? Siemens Healthineers is preparing a software update to resolve the described problems. The new software version VB10E will be distributed via Update Instruction XP031/25/S during the first quarter of 2026 free of charge. Our service organization will contact you to arrange a date to perform this corrective action. Please feel free to contact our service organization at 1-800-888-7436 for an earlier appointment. FDA recall Z-1175-2026 is Open, Classified for Interventional Fluoroscopic X-Ray System: LUMINOS Q.namix T; Siemens Material Number (SMN): 11574003; With Software Version VB10D-SP02. FDA reason: Ortho images acquired with preset automatic horizontal flip are not flipped and when acquiring single images, there is the possibility that an image of a previous patient may be processed. FDA action: On December 29, 2025 URGENT: MEDICAL DEVICE CORRECTION letters were sent to customers. Actions to be taken: Issue 1: Ortho images acquired with preset automatic horizontal flip are not flipped: For ortho examinations, no clinical protocols should be used where the automatic horizontal flip function is active. Issue 2: When acquiring single images, there is the possibility that an image of a previous patient may be processed: a. When acquiring single images with the Dynamic X.fluoro detector, the above-mentioned error message should be observed, and the system should be restarted when it appears. b. Images planned at the Bucky Wall Stand should be acquired on the basic unit or with a mobile detector. Should a single image on the Bucky Wall Stand in horizontal orientation be inevitable, the system must be restarted beforehand. How will the problem be resolved? Siemens Healthineers is preparing a software update to resolve the described problems. The new software version VB10E will be distributed via Update Instruction XP031/25/S during the first quarter of 2026 free of charge. Our service organization will contact you to arrange a date to perform this corrective action. Please feel free to contact our service organization at 1-800-888-7436 for an earlier appointment.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-1174-2026

Open, Classified

2026-01-27

Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; do not infer an AI-algorithm defect unless the FDA record says so. Confirm affected model, version, units, corrective action, and completion status locally.

recall: Z-1175-2026

Open, Classified

2026-01-27

Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; do not infer an AI-algorithm defect unless the FDA record says so. Confirm affected model, version, units, corrective action, and completion status locally.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance or approval.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: An X-ray pattern.

    Scope: Exact FDA submission. The packet directly states that the devices convert an X-ray pattern into a visible image; patient-positioning and procedure-specific input additions are not retained.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K250660: LUMINOS Q.namix T; LUMINOS Q.namix R

  2. Routing

    Source context, not route validation: Validate generator, detector, workstation, DICOM transfer, dose reporting, overlays, procedure records, displays, and fallback workflow.

    Scope: Product family. Current vendor materials are product-family evidence for K250660; confirm the exact cleared version, enabled options, deployment, and local compatibility.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · FDA K250660: LUMINOS Q.namix T; LUMINOS Q.namix R · Siemens LUMINOS Q.namix

  3. AI processing

    Source context, not route validation: Installed fluoroscopy or radiography system with release-specific detector, workstation, software, and procedure-room accessories.

    Scope: Product family. Current vendor materials are product-family evidence for K250660; confirm the exact cleared version, enabled options, deployment, and local compatibility.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · FDA K250660: LUMINOS Q.namix T; LUMINOS Q.namix R · Siemens LUMINOS Q.namix

  4. Returned objects

    Source context, not route validation: LUMINOS Q.namix T and LUMINOS Q.namix R are devices intended to visualize anatomical structures by converting an X-ray pattern into a visible image.

    Scope: Exact FDA submission. The exact packet supports a visible image of anatomical structures and diagnostic radiography/fluoroscopy images, not the current reformats, overlays, measurements, or guidance-view list.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K250660: LUMINOS Q.namix T; LUMINOS Q.namix R

  5. Viewer/worklist/report

    Unresolved route: LUMINOS Q.namix T and LUMINOS Q.namix R are devices intended to visualize anatomical structures by converting an X-ray pattern into a visible image.

    Scope: Exact FDA submission. The exact packet supports a visible image of anatomical structures and diagnostic radiography/fluoroscopy images, not the current reformats, overlays, measurements, or guidance-view list.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K250660: LUMINOS Q.namix T; LUMINOS Q.namix R

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Installed fluoroscopy or radiography system with release-specific detector, workstation, software, and procedure-room accessories.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K250660; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Integration
Validate generator, detector, workstation, DICOM transfer, dose reporting, overlays, procedure records, displays, and fallback workflow.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K250660; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Training
Only qualified radiologists, interventional physicians, surgeons, technologists, and other trained fluoroscopy professionals should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K250660; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, outputs, and enabled AI functions to K250660 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

Validate generator, detector, workstation, DICOM transfer, dose reporting, overlays, procedure records, displays, and fallback workflow.

product family · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.

product family · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K250660
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Fluoroscopy/Angiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-07-14
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
14Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 2 FDA recall candidates were manually reviewed: 2 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 2 postmarket candidate records; 2 have been reviewed (2 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-03 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

9 sources - 3 history items

Source ledger

  1. FDA K250660: LUMINOS Q.namix T; LUMINOS Q.namix R

    U.S. Food and Drug Administration - Published 2025-07-14 - Accessed 2026-09-19

    Scope: purpose, modality, anatomy, intendedUsers, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-1174-2026: Interventional Fluoroscopic X-Ray System: LUMINOS Q.namix R; Siemens Material Number (SMN): 11574002; With Software Version VB10D-SP02

    U.S. Food and Drug Administration - Published 2026-01-27 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. FDA recall Z-1175-2026: Interventional Fluoroscopic X-Ray System: LUMINOS Q.namix T; Siemens Material Number (SMN): 11574003; With Software Version VB10D-SP02

    U.S. Food and Drug Administration - Published 2026-01-27 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  5. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  6. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  7. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  8. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  9. Siemens LUMINOS Q.namix

    Siemens Healthineers - Accessed 2026-09-03

    Scope: productFamilyContext, workflowRole, implementationCapabilities

Research history

  1. K250660 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K180589

DR 800 with MUSICA Dynamic

Agfa HealthCare N.V.

Authorized purpose: DR 800 with MUSICA Dynamic is a digital radiography and dynamic-fluoroscopy system for routine radiography, positioning, gastrointestinal, urogenital, angiographic, and pediatric examinations across the labeled body regions; it is not a mammography system.

Modality
Fluoroscopy/Angiography
Anatomy
Multi-region
Decision
2018-04-05
FDA-cleared K243446

3DXR

GE Medical Systems SCS

Authorized purpose: 3DXR reconstructs cone-beam CT from interventional X-ray acquisitions and uses CleaRecon DL to reduce streak artifacts for display in the advanced workstation workflow.

Modality
Fluoroscopy/Angiography
Anatomy
Multi-region
Decision
2025-02-25
FDA-cleared K222070

EndoNaut

Therenva SAS

Authorized purpose: EndoNaut fuses planning images with live fluoroscopy and provides computerized navigation support for fluoroscopy-guided aneurysm repair, embolization, and peripheral-artery procedures involving the chest, abdomen, pelvis, neck, or lower limbs.

Modality
Fluoroscopy/Angiography
Anatomy
Multi-region
Decision
2022-10-25
FDA-cleared K212383

EndoNaut

Therenva SAS

EndoNaut overlays preoperative three-dimensional vascular anatomy on live fluoroscopy and supports semi-automatic registration and motion detection for selected aneurysm, angioplasty, stenting, and embolization procedures.

Modality
Fluoroscopy/Angiography
Anatomy
Multi-region
Decision
2021-08-31

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history